Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Clinical trial NCT03444870 · TERMINATED

Trial details

NCT number: NCT03444870
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2018-06-06
Primary completion: 2022-12-28
Enrollment: 1053

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.